Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...
Sensitivity analysis after including all patient-years with no history of asthma related healthcare ...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...
Sensitivity analysis after including all patient-years with no history of asthma related healthcare ...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
DOI
Add to ORKG